GaBI Journal Publishes ASBM Whitepaper on Medicare Part D Price Setting
Safe Biologics
FEBRUARY 1, 2024
In January, the Generics and Biosimilars Initiative (GaBI) published a whitepaper entitled “ Medicare Drug Price Negotiations: Impact on Healthcare Development and Patient Access to Medicines” The paper’s content is drawn from a webinar on the same topic hosted by ASBM and GaBI on July 26, 2023.
Let's personalize your content